GENPAK

Welcome to the Brand page for “GENPAK”, which is offered here for Bio-engineered cellular material which is a component of pharmaceutical and therapeutic preparations for use in the treatment of cancer, aids, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, hematologic diseases, immune diseases and hormone deficiencies, a packaging cell line that produces retroviral gene therapy vectors; pharmaceutical preparations for use in the treatment of cancer, aids, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, and hormone deficiencies, and for packaging cell lines for use in the treatment of cancer, aids, metabolic diseases, neurodegenerative diseases, cardiovascular diseases and hormone deficiencies;.

Its status is currently believed to be active. Its class is unavailable. “GENPAK” is believed to be currently owned by “Johnson & Johnson Development Corporation”.